Horsemen's representatives told the Ohio Horse Racing Commission March 30 that equine medication rules, which the commission is reviewing, should be breed-specific in nature.
The New York Gaming Commission, during a Jan. 21 public hearing, heard the pros and cons of having different medication rules for Thoroughbred and Standardbred racehorses.
Amid another call for separate medication rules for Thoroughbreds and Standardbreds, the Ohio State Racing Commission has indicated it's not prepared to adopt a uniform national drug policy.
The United States Trotting Association, which in late September dropped out of the Racing Medication and Testing Consortium and rejected model medication rules approved by RCI, has created its own drug advisory committee.
The United States Trotting Association, citing differences in breeds, said Sept. 26 it has ended its membership in the Racing Medication and Testing Consortium and has rejected the proposed national model drug rules.
Most Popular Stories
- Curlin to Hill 'n' Dale in 2016
- USADA Contributes to Steroid Crackdown
- Rachel's Valentina, Tonasah Head Spinaway
- Del Mar Debutante Field Talented and Diverse
- Back to Business for Liam's Map in Woodward
- Spendthrift Out Front with Top Sires' Fees
- Goldy Espony on Streak Entering Glens Falls
- Suffolk to Reopen for First of Three Programs
- No Stability with Texas Commission Funding
- Takeover Target Heads Saranac